Ribeyrolle Christian Antoine Lucien 4

What Happened

• Christian Antoine Lucien Ribeyrolle, SVP, Biomaterials at Rayonier Advanced Materials (RYAM), converted 8,940 restricted stock units (RSUs) into 8,940 shares of common stock and was also recorded as receiving a grant/award of 9,504 RSUs on 2026-03-01.
• Both the conversion and the award are reported as derivative transactions at a conversion price of $0.00 per share, so no cash payment was made in connection with the conversion. The filing lists the derivative conversion as an "acquired" and a corresponding "disposed" derivative entry (technical reporting of RSU-to-share conversion).

Key Details

• Transaction date: 2026-03-01; Form 4 filed: 2026-03-03 (timely filing).
• Conversion price: $0.00 per share; monetary consideration: $0.
• Shares received from conversion: 8,940 common shares. Additional award: 9,504 RSUs (each RSU represents a contingent right to one share).
• Shares owned after the transactions: not specified in the excerpt of the filing provided.
• Footnotes: F1 confirms the conversion of 8,940 RSUs into common stock with no cash payment; F2 clarifies each RSU equals one share.
• Transaction type: derivative conversion/award (not an open-market purchase or sale).

Context

• RSU conversions and RSU awards are compensation-related, not traditional purchases — they reflect vesting/conversion of deferred equity and new grants rather than an insider "buying" or "selling" stock in the market.
• The filing does not show a simultaneous sale of the converted shares; therefore this is not a cashless exercise followed by an immediate sale. For retail investors, such grants and conversions are common executive compensation events and are informational rather than a direct signal of buying or selling intent.